LFWD vs. RBOT, MLSS, NTRB, CLGN, COCH, BGXX, NHIQ, RFL, DKDCA, and SNSE
Should you be buying ReWalk Robotics stock or one of its competitors? The main competitors of ReWalk Robotics include Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Bright Green (BGXX), NantHealth (NHIQ), Rafael (RFL), Data Knights Acquisition (DKDCA), and Sensei Biotherapeutics (SNSE). These companies are all part of the "medical" sector.
ReWalk Robotics (NASDAQ:LFWD) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.
ReWalk Robotics has higher revenue and earnings than Vicarious Surgical. ReWalk Robotics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
In the previous week, ReWalk Robotics had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for ReWalk Robotics and 1 mentions for Vicarious Surgical. Vicarious Surgical's average media sentiment score of 0.25 beat ReWalk Robotics' score of 0.15 indicating that Vicarious Surgical is being referred to more favorably in the news media.
26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Comparatively, 11.7% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
ReWalk Robotics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.
Vicarious Surgical received 6 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 38.10% of users gave Vicarious Surgical an outperform vote.
ReWalk Robotics presently has a consensus price target of $9.00, indicating a potential upside of 73.75%. Vicarious Surgical has a consensus price target of $0.67, indicating a potential upside of 120.53%. Given Vicarious Surgical's higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than ReWalk Robotics.
Vicarious Surgical has a net margin of 0.00% compared to ReWalk Robotics' net margin of -159.76%. ReWalk Robotics' return on equity of -28.19% beat Vicarious Surgical's return on equity.
Summary
ReWalk Robotics beats Vicarious Surgical on 9 of the 17 factors compared between the two stocks.
Get ReWalk Robotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ReWalk Robotics Competitors List
Related Companies and Tools
